Maze Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MAZE and other ETFs, options, and stocks.About MAZE
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular, and related metabolic, or CVRM diseases. Its pipeline includes the Compass platform, which allows it to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process to refer a variant functionalization.
MAZE Key Statistics
Stock Snapshot
As of today, Maze Therapeutics(MAZE) shares are valued at $40.12. The company's market cap stands at 1.93B, with a P/E ratio of -18.36.
During the trading session on 2026-01-14, Maze Therapeutics(MAZE) shares reached a daily high of $41.78 and a low of $38.00. At a current price of $40.12, the stock is +5.6% higher than the low and still -4.0% under the high.
Trading activity shows a volume of 59.66K, compared to an average daily volume of 304.39K.
The stock's 52-week range extends from a low of $6.71 to a high of $43.29.
The stock's 52-week range extends from a low of $6.71 to a high of $43.29.
MAZE News
New insider activity at Maze Therapeutics, Inc. ( (MAZE) ) has taken place on January 8, 2026. Claim 70% Off TipRanks Premium Director Catherine Sohn has offl...